Parvovirus vectors: Use and optimisation in cancer gene therapy

Boris Blechacz, Stephen J Russell

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

With the increasing incidence and mortality of cancer worldwide, there is an urgent need for new therapeutic approaches. Gene therapy is one such approach and preliminary data are promising. Viral and nonviral vector systems for gene delivery are available, but most of the current systems suffer from disadvantages such as low transfection efficiencies, in vivo instability, targeting problems, mutagenic potential and immunogenicity. Viruses of the Parvoviridae family, which are characterised by their oncotropism, oncosuppression, long-term gene expression and human apathogenicity, potentially offer advantages as viral vectors. This article evaluates their usefulness in gene therapy strategies for cancer.

Original languageEnglish (US)
JournalExpert Reviews in Molecular Medicine
Volume6
Issue number16
DOIs
StatePublished - Jul 2004

Fingerprint

Gene therapy
Parvovirus
Neoplasm Genes
Genetic Therapy
Parvoviridae
Gene Transfer Techniques
Viruses
Gene expression
Transfection
Neoplasms
Genes
Gene Expression
Mortality
Incidence
Therapeutics

Keywords

  • AAV
  • ARP
  • Cancer gene therapy
  • Parvovirus
  • Viral vector

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)
  • Molecular Medicine

Cite this

Parvovirus vectors : Use and optimisation in cancer gene therapy. / Blechacz, Boris; Russell, Stephen J.

In: Expert Reviews in Molecular Medicine, Vol. 6, No. 16, 07.2004.

Research output: Contribution to journalArticle

@article{7b7bfcc329ed4dfc8b10ffc1be561836,
title = "Parvovirus vectors: Use and optimisation in cancer gene therapy",
abstract = "With the increasing incidence and mortality of cancer worldwide, there is an urgent need for new therapeutic approaches. Gene therapy is one such approach and preliminary data are promising. Viral and nonviral vector systems for gene delivery are available, but most of the current systems suffer from disadvantages such as low transfection efficiencies, in vivo instability, targeting problems, mutagenic potential and immunogenicity. Viruses of the Parvoviridae family, which are characterised by their oncotropism, oncosuppression, long-term gene expression and human apathogenicity, potentially offer advantages as viral vectors. This article evaluates their usefulness in gene therapy strategies for cancer.",
keywords = "AAV, ARP, Cancer gene therapy, Parvovirus, Viral vector",
author = "Boris Blechacz and Russell, {Stephen J}",
year = "2004",
month = "7",
doi = "10.1017/S1462399404008026",
language = "English (US)",
volume = "6",
journal = "Expert Reviews in Molecular Medicine",
issn = "1462-3994",
publisher = "Cambridge University Press",
number = "16",

}

TY - JOUR

T1 - Parvovirus vectors

T2 - Use and optimisation in cancer gene therapy

AU - Blechacz, Boris

AU - Russell, Stephen J

PY - 2004/7

Y1 - 2004/7

N2 - With the increasing incidence and mortality of cancer worldwide, there is an urgent need for new therapeutic approaches. Gene therapy is one such approach and preliminary data are promising. Viral and nonviral vector systems for gene delivery are available, but most of the current systems suffer from disadvantages such as low transfection efficiencies, in vivo instability, targeting problems, mutagenic potential and immunogenicity. Viruses of the Parvoviridae family, which are characterised by their oncotropism, oncosuppression, long-term gene expression and human apathogenicity, potentially offer advantages as viral vectors. This article evaluates their usefulness in gene therapy strategies for cancer.

AB - With the increasing incidence and mortality of cancer worldwide, there is an urgent need for new therapeutic approaches. Gene therapy is one such approach and preliminary data are promising. Viral and nonviral vector systems for gene delivery are available, but most of the current systems suffer from disadvantages such as low transfection efficiencies, in vivo instability, targeting problems, mutagenic potential and immunogenicity. Viruses of the Parvoviridae family, which are characterised by their oncotropism, oncosuppression, long-term gene expression and human apathogenicity, potentially offer advantages as viral vectors. This article evaluates their usefulness in gene therapy strategies for cancer.

KW - AAV

KW - ARP

KW - Cancer gene therapy

KW - Parvovirus

KW - Viral vector

UR - http://www.scopus.com/inward/record.url?scp=31044439428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31044439428&partnerID=8YFLogxK

U2 - 10.1017/S1462399404008026

DO - 10.1017/S1462399404008026

M3 - Article

C2 - 15387896

AN - SCOPUS:31044439428

VL - 6

JO - Expert Reviews in Molecular Medicine

JF - Expert Reviews in Molecular Medicine

SN - 1462-3994

IS - 16

ER -